More Novartis jobs cut in New York as plant suffers drawn-out drawdown – FiercePharma Manufacturing
0
Novartis ($NVS) continues the protracted drawdown at its Diovan plant in New York, telling the state nearly two dozen more jobs will be whacked starting at the end of March. It will be the third round of cuts since the Swiss drugmaker announced nearly a year ago that it would whittle away all of the 525 jobs at the plant by 2016 and then close and demolish it.
Read more – FiercePharma Manufacturing